Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

about

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

Item

http://www.wikidata.org/entity/Q57069346

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@en

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@nl

type

Item

label

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@en

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@nl

altLabel

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@en

prefLabel

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@en

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@nl

P1476

Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro

@en

P2093

Feifang Zhang

http://www.w3.org/2001/XMLSchema#string

Qun Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

EMT and dissemination precede pancreatic tumor formation

Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells.

Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.

Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation.

Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide

BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro.

P31

scholarly article

P356

10.3892/MMR.2018.9511

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30272359

http://www.w3.org/2001/XMLSchema#string

P921

molecular medicine

molecular biology

P932

6236300

http://www.w3.org/2001/XMLSchema#string